Myocyte hypertrophy in the transplanted heart. A morphometric analysis.

Area of Science:

• Cardiology
• Transplantation Immunology
• Cellular Biology

Background:

• Long-term effects of immunosuppression and donor heart ischemia on cardiac transplants require further definition.
• Cyclosporine can induce hypertension, potentially impacting cardiac structure post-transplantation.
• Donor heart ischemic time is a critical factor in transplant success.

Purpose of the Study:

• To evaluate long-term ultrastructural changes in transplanted hearts.
• To assess the impact of cyclosporine and donor heart ischemic time on myocyte hypertrophy.
• To compare cardiac changes between on-site and distantly procured donor hearts.

Main Methods:

• Endomyocardial biopsies from 20 cardiac transplant recipients three years post-transplantation.
• Biopsies analyzed ultrastructurally and divided into four groups based on donor heart procurement (on-site vs. distant) and immunosuppression (cyclosporine vs. conventional).
• Statistical analysis of myocyte width in different study groups.

Main Results:

• All groups exhibited significant myocyte hypertrophy compared to normal myocardium.
• Distantly procured donor hearts showed significantly greater myocyte width than on-site procured hearts.
• No significant difference in myocyte width was observed between cyclosporine and conventional immunosuppression groups.

Conclusions:

• Myocyte hypertrophy at three years post-transplantation is not significantly greater with cyclosporine-based immunosuppression compared to conventional therapy.
• Distantly procured donor hearts experience more significant myocyte hypertrophy.
• Prioritizing on-site procured donor hearts may mitigate hypertrophy-related risks, such as ventricular arrhythmias.